NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $45,353 | -3.5% | 17,511 | +52.1% | 0.00% | – |
| Q1 2023 | $46,985 | -18.7% | 11,516 | 0.0% | 0.00% | – |
| Q4 2022 | $57,810 | -44.9% | 11,516 | +43.2% | 0.00% | -100.0% |
| Q3 2022 | $105,000 | +1.9% | 8,040 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $103,000 | -16.3% | 8,040 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $123,000 | -30.5% | 8,040 | -19.3% | 0.00% | 0.0% |
| Q4 2021 | $177,000 | +311.6% | 9,968 | +383.6% | 0.00% | – |
| Q3 2021 | $43,000 | +4.9% | 2,061 | +0.1% | 0.00% | – |
| Q2 2021 | $41,000 | -28.1% | 2,058 | +4.3% | 0.00% | – |
| Q1 2021 | $57,000 | – | 1,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |